PharmacoEconomics invites the submission of papers (original research, reviews and opinion pieces) on improving transparency in decision models for a themed issue of the journal to be published in 2019 and guest edited by Paul Tappenden (University of Sheffield) and Jaime Caro (London School of Economics and McGill University). We encourage papers from the perspectives of a variety of stakeholders including methodologists, payers, health technology assessment bodies, analysts, pharmaceutical industry, advocacy groups and software developers. Country-specific perspectives are also encouraged. Papers can be either methodological or applied.
Topics of interest include:
- Why the need for change?
- Advantages and disadvantages of transparency
- What would an ideal world look like?
- Challenges and solutions in moving to a more transparent world
- Current open source and transparency initiatives
- Software programs and hosting platforms
- Economic evaluations using open source models
- Methods and techniques for transparent model programming (e.g. housekeeping, colour coding, separating inputs, calculations and outputs, breaking up formulae, other approaches)
- Protecting intellectual property rights and funding in an open source world
Please submit an abstract describing your proposed paper by September 30th, 2018 to email@example.com. Full papers will be invited by October 30th 2018 and manuscripts due early 2019.